Skip to main content
Erschienen in:

29.07.2024 | Cardiac

Cardiovascular magnetic resonance parametric mapping in the risk stratification of patients affected by chronic myocarditis

verfasst von: Davide Vignale, Elisa Bruno, Anna Palmisano, Simone Barbieri, Axel Bartoli, Giovanni Peretto, Andrea Villatore, Giacomo De Luca, Antonio Esposito

Erschienen in: European Radiology | Ausgabe 2/2025

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Chronic myocardial inflammation is the substrate for arrhythmias and dilated cardiomyopathy onset, causing morbidity and mortality. Cardiovascular magnetic resonance (CMR) is the noninvasive gold standard for myocardial inflammation detection, due to the high sensitivity of the parametric mapping techniques. However, the potential prognostic capabilities of CMR mapping have not been studied in the setting of chronic myocarditis.

Methods

This is a retrospective study on consecutive patients undergoing CMR with suspicion of chronic myocarditis from September 2017 to November 2021. CMR was acquired according to 2018 Lake Louise Criteria recommendations. The outcome (chronic heart failure, recurrent chronic myocarditic chest pain, ICD/PM implantation, arrhythmias [Lown class ≥ 2]) was collected at follow-up. The extent and degree of native T1, T2, and extracellular volume fraction alterations were used to create multivariate binary logistic regression models for outcome prediction, with or without left ventricle ejection fraction; their AUCs were compared with DeLong test. Differences between other parameters were assessed using Chi-square test, Fisher’s exact test, or Mann-Whitney U-test.

Results

The population included 88 patients (age 43 [32–52] yo), mostly male (53/88, 60%). After a median follow-up of 21 (17–34) months, 31/88 (35%) patients experienced the outcome. The model based on the extension of mapping alterations and LV dysfunction reached a good predictability (AUC 0.71). The model based on the intensity of mapping alterations and LV dysfunction had a very good performance (AUC 0.80).

Conclusion

The quantitative analysis of CMR mapping parameters indicative of myocardial damage severity may improve risk stratification in patients with chronic myocarditis.

Clinical relevance statement

The intensity of myocardial damage, assessed as the degree of native T1, T2, and ECV alteration, together with left ventricle dysfunction, improved patient risk stratification. Further prospective studies will be necessary for validation before clinical application.

Key Points

  • Risk stratification of patients affected by chronic myocarditis is an unmet clinical need.
  • Cardiovascular MRI (CMR) can role in risk stratification thanks to its multiparametric capabilities of tissue characterization.
  • A model based on CMR parametric mapping and left ventricle ejection fraction can predict arrhythmia, heart failure, and recurrent symptoms.

Graphical Abstract

Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat De Luca G, Campochiaro C, Sartorelli S et al (2020) Therapeutic strategies for virus-negative myocarditis: a comprehensive review. Eur J Intern Med 77:9–17CrossRefPubMed De Luca G, Campochiaro C, Sartorelli S et al (2020) Therapeutic strategies for virus-negative myocarditis: a comprehensive review. Eur J Intern Med 77:9–17CrossRefPubMed
7.
15.
Zurück zum Zitat Friedrich MG, Sechtem U, Schulz-Menger J et al (2009) Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper. J Am Coll Cardiol 53:1475–1487CrossRefPubMedPubMedCentral Friedrich MG, Sechtem U, Schulz-Menger J et al (2009) Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper. J Am Coll Cardiol 53:1475–1487CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Schulz-Menger J, Bluemke DA, Bremerich J et al (2020) Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update: Society for Cardiovascular Magnetic Resonance (SCMR): Board of Trustees Task Force on Standardized Post-Processing. J Cardiovasc Magn Reson 22 Schulz-Menger J, Bluemke DA, Bremerich J et al (2020) Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update: Society for Cardiovascular Magnetic Resonance (SCMR): Board of Trustees Task Force on Standardized Post-Processing. J Cardiovasc Magn Reson 22
20.
Zurück zum Zitat Cerqueira MD, Weissman NJ, Dilsizian V et al (2002) Standardized myocardial sementation and nomenclature for tomographic imaging of the heart: A Statement for Healthcare Professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539–542CrossRefPubMed Cerqueira MD, Weissman NJ, Dilsizian V et al (2002) Standardized myocardial sementation and nomenclature for tomographic imaging of the heart: A Statement for Healthcare Professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539–542CrossRefPubMed
22.
Zurück zum Zitat Bozkurt B, Coats AJ, Tsutsui H et al (2021) Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition. J Card Fail. https://doi.org/10.1016/j.cardfail.2021.01.022 Bozkurt B, Coats AJ, Tsutsui H et al (2021) Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition. J Card Fail. https://​doi.​org/​10.​1016/​j.​cardfail.​2021.​01.​022
31.
Zurück zum Zitat Spieker M, Katsianos E, Gastl M et al (2018) T2 mapping cardiovascular magnetic resonance identifies the presence of myocardial inflammation in patients with dilated cardiomyopathy as compared to endomyocardial biopsy. Eur Hear J Cardiovasc Imaging 19:574–582. https://doi.org/10.1093/ehjci/jex230CrossRef Spieker M, Katsianos E, Gastl M et al (2018) T2 mapping cardiovascular magnetic resonance identifies the presence of myocardial inflammation in patients with dilated cardiomyopathy as compared to endomyocardial biopsy. Eur Hear J Cardiovasc Imaging 19:574–582. https://​doi.​org/​10.​1093/​ehjci/​jex230CrossRef
34.
Zurück zum Zitat Tschöpe C, Ammirati E, Bozkurt B et al (2021) Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol 18:169–193CrossRefPubMed Tschöpe C, Ammirati E, Bozkurt B et al (2021) Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol 18:169–193CrossRefPubMed
Metadaten
Titel
Cardiovascular magnetic resonance parametric mapping in the risk stratification of patients affected by chronic myocarditis
verfasst von
Davide Vignale
Elisa Bruno
Anna Palmisano
Simone Barbieri
Axel Bartoli
Giovanni Peretto
Andrea Villatore
Giacomo De Luca
Antonio Esposito
Publikationsdatum
29.07.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 2/2025
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-024-10978-z

Neu im Fachgebiet Radiologie

Ringen um den richtigen Umgang mit Zufallsbefunden

Wenn 2026 in Deutschland das Lungenkrebsscreening mittels Low-Dose-Computertomografie (LDCT) eingeführt wird, wird es auch viele Zufallsbefunde ans Licht bringen. Das birgt Chancen und Risiken.

Bald 5% der Krebserkrankungen durch CT verursacht

Die jährlich rund 93 Millionen CTs in den USA könnten künftig zu über 100.000 zusätzlichen Krebserkrankungen führen, geht aus einer Modellrechnung hervor. Damit würde eine von 20 Krebserkrankungen auf die ionisierende Strahlung bei CT-Untersuchungen zurückgehen.

Röntgen-Thorax oder LDCT fürs Lungenscreening nach HNSCC?

Personen, die an einem Plattenepithelkarzinom im Kopf-Hals-Bereich erkrankt sind, haben ein erhöhtes Risiko für Metastasen oder zweite Primärmalignome der Lunge. Eine Studie hat untersucht, wie die radiologische Überwachung aussehen sollte.

Statine: Was der G-BA-Beschluss für Praxen bedeutet

Nach dem G-BA-Beschluss zur erweiterten Verordnungsfähigkeit von Lipidsenkern rechnet die DEGAM mit 200 bis 300 neuen Dauerpatienten pro Praxis. Im Interview erläutert Präsidiumsmitglied Erika Baum, wie Hausärztinnen und Hausärzte am besten vorgehen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.